A cancer specialist on an expert panel that voted against keeping Avastin's approval for *** cancer intact explained his decision. He couldn't imagine recommending a drug that only limits progression of cancer without lengthening patient's
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/10/13/141306235/avastin-for-breast-cancer-hope-versus-false-hope?ft=1&f=103537970
Posted
Oct 13 2011, 07:27 AM
by
NPR Blogs: Shots - Health Blog